Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Nov;130(5):628-636.
doi: 10.1111/bju.15771. Epub 2022 Jun 5.

NeuroSAFE in radical prostatectomy increases the rate of nerve-sparing surgery without affecting oncological outcome

Margaretha A van der Slot  1   2   3 , Michael A den Bakker  1   2 , Tamara S C Tan  4 , Sebastiaan Remmers  4 , Martijn B Busstra  1   4 , Melanie Gan  1   3 , Sjoerd Klaver  1   3 , John B W Rietbergen  1   5 , Charlotte F Kweldam  1   2 , Mike Kliffen  1   2 , Karen E Hamoen  1   2 , Leo M Budel  1   2 , Natascha N T Goemaere  1   2 , Jozien Helleman  4 , Chris H Bangma  4 , Monique J Roobol  4 , Geert J L H van Leenders  6 ; Anser Prostate Cancer Network
Affiliations
Review

NeuroSAFE in radical prostatectomy increases the rate of nerve-sparing surgery without affecting oncological outcome

Margaretha A van der Slot et al. BJU Int. 2022 Nov.

Abstract

Objectives: To investigate the impact of intra-operative neurovascular structure-adjacent frozen-section examination (NeuroSAFE) on the rate of nerve-sparing surgery (NSS) and oncological outcome in a large radical prostatectomy (RP) cohort.

Patients and methods: Between January 2016 and December 2020, 1756 prostate cancer patients underwent robot-assisted RP, of whom 959 (55%) underwent this with NeuroSAFE and 797 (45%) without (control cohort). In cases where NeuroSAFE showed tumour in the margin, a secondary resection was performed. The effect of NeuroSAFE on NSS and positive surgical margin (PSM) status was analysed using logistic regression. Cox regression was used to identify predictors of biochemical recurrence-free survival (BCRFS).

Results and limitations: Patients in the NeuroSAFE cohort had a higher tumour grade (P < 0.001) and clinical stage (P < 0.001) than those in the control cohort. NeuroSAFE enabled more frequent NSS for both pT2 (93% vs 76%; P < 0.001) and pT3 disease (83% vs 55%; P < 0.001). In adjusted analysis, NeuroSAFE resulted in more frequent unilateral (odds ratio [OR] 3.90, 95% confidence interval (CI) 2.90-5.30; P < 0.001) and bilateral (OR 5.22, 95% CI 3.90-6.98; P < 0.001) NSS. While the PSM rate decreased from 51% to 42% in patients with pT3 stage disease (P = 0.031), NeuroSAFE was not an independent predictor of PSM status (OR 0.85, 95% CI 0.68-1.06; P = 0.2) in the entire cohort. Patients who underwent NeuroSAFE had better BCRFS compared to the control cohort (hazard ratio 0.62, 95% CI 0.45-0.84; P = 0.002). This study is limited by its comparison with a historical cohort and lack of functional outcomes.

Conclusions: NeuroSAFE enables more unilateral and bilateral NSS without negatively affecting surgical margin status and biochemical recurrence. This validation study provides a comprehensive overview of the implementation, evaluation and intra-operative decision making associated with NeuroSAFE in clinical practice.

Keywords: frozen-section analysis; nerve-sparing; neurosafe; prostate cancer; robot-assisted radical prostatectomy.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Study flow diagram. NSS, nerve‐sparing surgery; RP, radical prostatectomy. [Colour figure can be viewed at wileyonlinelibrary.com]
Fig. 2
Fig. 2
(A) Radical prostatectomy dissection planes in relation to the neurovascular bundle (NVB). (B) Overview of categorization of dissection plane in relation to levels of nerve‐sparing. [Colour figure can be viewed at wileyonlinelibrary.com]
See this image and copyright information in PMC

References

    1. Preisser F, Marchioni M, Nazzani S et al. Trend of adverse stage migration in patients treated with radical prostatectomy for localized prostate cancer. Eur Urol Oncol 2018; 1: 160–8 - PubMed
    1. Arroyo C, Martini A, Wang J, Tewari AK. Anatomical, surgical and technical factors influencing continence after radical prostatectomy. Ther Adv Urol 2019; 11: 1756287218813787 - PMC - PubMed
    1. Tal R, Alphs HH, Krebs P, Nelson CJ, Mulhall JP. Erectile function recovery rate after radical prostatectomy: A meta‐analysis. J Sex Med 2009; 6: 2538–46 - PMC - PubMed
    1. Suardi N, Moschini M, Gallina A et al. Nerve‐sparing approach during radical prostatectomy is strongly associated with the rate of postoperative urinary continence recovery. BJU Int 2013; 111: 717–22 - PubMed
    1. Avulova S, Zhao Z, Lee D et al. The effect of nerve sparing status on sexual and urinary function: 3‐year results from the CEASAR study. J Urol 2018; 199: 1202–9 - PubMed

Publication types